Christopher Hoffmann, MD

Faculty

Titles:

Assistant Professor, Medicine

SciVal:

SciVal Link

Dr Hoffmann is an Assistant Professor of Medicine in the Division of Infectious Diseases with a joint appointment in the Division of Internal Medicine.  His clinical work includes inpatient and outpatient HIV care and inpatient general infectious diseases consults and general internal medicine.  His primary research interest is in reducing HIV and TB associated mortality in low and middle income countries.  He work spans several disciplines including (1) clinical epidemiology and clinical outcomes related research with HIV treatment cohorts, (2) population-level epidemiology of TB, HIV, and hepatitis B, (3) operational research around screening and testing for both TB and HIV (including in marginalized populations such as correctional facility inmates), (4) implementation science to understand and improve scale-up of proven interventions through the use of pragmatic clinical trials, (5) health economics to contextualize operational research and implementation science findings. The majority of his work is in southern Africa.  Current projects include assessments of interventions to increase entry-into-care following HIV diagnosis, retention in HIV care, managing HIV and TB care transitions, improved TB intensified case finding, TB and HIV management in correctional facilities, and adapting quality improvement approaches for primary health clinics in South Africa.  He is also involved in several projects aimed at assessing current HIV care with the goal of contributing to improving outcomes while using existing antiretroviral agents and delivery infrastructure. I also teach a module on global health delivery at the School of Medicine.

Categories

Events

«

May 2019

»
S
M
T
W
T
F
S
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
·

Projects

Impact of diabetes on TB treatment outcomes...

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes...

Read More

Understanding the impact of combined TB and...

We are developing models to understand the overlap of TB and HIV in three epidemiologically distinct settings (Canada, India,...

Read More

Evaluation of a novel serum biosignature for...

This study will use multiple high-throughput modalities, including LC-MS/MS and RNA-seq, to detect a panel of host metabolites...

Read More

Comparative implementation and...

We are conducting a randomized comparative implementation trial across 56 sites in rural South Africa to evaluate three...

Read More

Options for Patient-Centered Delivery of...

This individually randomized trial is evaluating the relative effectiveness of self-administered therapy, directly observed...

Read More